DE60005609D1 - Bizyklische Amino-Pyrazinon-Derivate, verfahren zu deren Herstellung und pharmazeutische Zusammensetzungen die diese enthalten - Google Patents

Bizyklische Amino-Pyrazinon-Derivate, verfahren zu deren Herstellung und pharmazeutische Zusammensetzungen die diese enthalten

Info

Publication number
DE60005609D1
DE60005609D1 DE60005609T DE60005609T DE60005609D1 DE 60005609 D1 DE60005609 D1 DE 60005609D1 DE 60005609 T DE60005609 T DE 60005609T DE 60005609 T DE60005609 T DE 60005609T DE 60005609 D1 DE60005609 D1 DE 60005609D1
Authority
DE
Germany
Prior art keywords
processes
preparation
pharmaceutical compositions
compositions containing
bicyclic amino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60005609T
Other languages
English (en)
Other versions
DE60005609T2 (de
Inventor
Nanteuil Guillaume De
Philippe Gloanec
Tony Verbeuren
Alain Rupin
Marie-Odile Vallez
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratoires Servier SAS
Original Assignee
Laboratoires Servier SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoires Servier SAS filed Critical Laboratoires Servier SAS
Application granted granted Critical
Publication of DE60005609D1 publication Critical patent/DE60005609D1/de
Publication of DE60005609T2 publication Critical patent/DE60005609T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE60005609T 1999-06-15 2000-06-15 Bizyklische Amino-Pyrazinon-Derivate, verfahren zu deren Herstellung und pharmazeutische Zusammensetzungen die diese enthalten Expired - Lifetime DE60005609T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9907538 1999-06-15
FR9907538A FR2795072B1 (fr) 1999-06-15 1999-06-15 Nouveaux derives bicycliques d'amino-pyrazinones, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Publications (2)

Publication Number Publication Date
DE60005609D1 true DE60005609D1 (de) 2003-11-06
DE60005609T2 DE60005609T2 (de) 2004-08-05

Family

ID=9546789

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60005609T Expired - Lifetime DE60005609T2 (de) 1999-06-15 2000-06-15 Bizyklische Amino-Pyrazinon-Derivate, verfahren zu deren Herstellung und pharmazeutische Zusammensetzungen die diese enthalten

Country Status (23)

Country Link
US (1) US6277851B1 (de)
EP (1) EP1069132B1 (de)
JP (1) JP3364472B2 (de)
KR (1) KR100456796B1 (de)
CN (1) CN1147489C (de)
AT (1) ATE251177T1 (de)
AU (1) AU766194B2 (de)
BR (1) BR0002643A (de)
CA (1) CA2312206C (de)
DE (1) DE60005609T2 (de)
DK (1) DK1069132T3 (de)
EA (1) EA003209B1 (de)
ES (1) ES2208239T3 (de)
FR (1) FR2795072B1 (de)
HK (1) HK1032236A1 (de)
HU (1) HUP0002277A3 (de)
NO (1) NO316650B1 (de)
NZ (1) NZ505149A (de)
PL (1) PL199522B1 (de)
PT (1) PT1069132E (de)
SE (1) SE1069132T5 (de)
SI (1) SI1069132T1 (de)
ZA (1) ZA200003034B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001064678A2 (en) * 2000-02-29 2001-09-07 Bristol-Myers Squibb Pharma Company Inhibitors of hepatitis c virus ns3 protease
FR2818277B1 (fr) * 2000-12-14 2003-01-24 Servier Lab Nouveaux derives bicycliques d'amino-pyrazinones, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
AU2003243657A1 (en) * 2002-06-26 2004-01-19 Bristol-Myers Squibb Company Amino-bicyclic pyrazinones and pyridinones
FR2867780B1 (fr) * 2004-03-19 2006-05-19 Servier Lab Nouveaux derives de 4-oxo-4,6,7,8-tetrahydropyrrolo (1,2-a) pyrazine-6-carboxamides, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
WO2013111107A1 (en) * 2012-01-27 2013-08-01 Novartis Ag Aminopyridine derivatives as plasma kallikrein inhibitors

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05117276A (ja) * 1991-10-23 1993-05-14 Sumitomo Pharmaceut Co Ltd 新規な3環性キノキサリンジオン誘導体
HUT77651A (hu) * 1994-12-22 1998-07-28 Biochem Pharma Inc. Oxazolo- és tiazolo[3,2-a]piridin-, pirrolo[1,2-a]pirazin- és pirido[2,1-c][1,4]tiazin-karboxamido-arginin-származékok, eljárás ezek előállítására és az ezeket tartalmazó gyógyszerkészítmények
WO1996030396A1 (en) * 1995-03-24 1996-10-03 Molecumetics Ltd. β-SHEET MIMETICS AND USE THEREOF AS PROTEASE INHIBITORS
CA2245811A1 (en) * 1996-02-22 1997-08-28 Merck & Co., Inc. Pyridinone thrombin inhibitors
WO1997048706A1 (en) * 1996-06-18 1997-12-24 Warner-Lambert Company Pyrrolo[1,2-a]pyrazine-1,4-dione serine protease inhibitors
AU4172397A (en) * 1996-09-06 1998-03-26 Biochem Pharma Inc. Lactam inhibitors of thrombin
JP2001502691A (ja) * 1996-10-24 2001-02-27 メルク エンド カンパニー インコーポレーテッド トロンビン阻害剤
US5792779A (en) * 1997-02-19 1998-08-11 Merck & Co., Inc. Pyridinone thrombin inhibitors
AU740447B2 (en) * 1997-09-23 2001-11-01 Merck & Co., Inc. Thrombin inhibitors

Also Published As

Publication number Publication date
ES2208239T3 (es) 2004-06-16
AU766194B2 (en) 2003-10-09
ZA200003034B (en) 2001-01-11
SI1069132T1 (en) 2003-12-31
NO20002941D0 (no) 2000-06-08
PL340784A1 (en) 2000-12-18
PL199522B1 (pl) 2008-09-30
HU0002277D0 (en) 2000-08-28
HUP0002277A3 (en) 2002-12-28
NO316650B1 (no) 2004-03-22
EP1069132B1 (de) 2003-10-01
ATE251177T1 (de) 2003-10-15
BR0002643A (pt) 2001-01-02
KR20010066846A (ko) 2001-07-11
CA2312206A1 (fr) 2000-12-15
CN1147489C (zh) 2004-04-28
KR100456796B1 (ko) 2004-11-10
NZ505149A (en) 2001-01-26
HK1032236A1 (en) 2001-07-13
EA200000527A3 (ru) 2001-04-23
US6277851B1 (en) 2001-08-21
EA200000527A2 (ru) 2000-12-25
EA003209B1 (ru) 2003-02-27
JP2001026592A (ja) 2001-01-30
PT1069132E (pt) 2004-02-27
DK1069132T3 (da) 2004-02-02
DE60005609T2 (de) 2004-08-05
EP1069132A1 (de) 2001-01-17
FR2795072B1 (fr) 2001-07-27
SE1069132T5 (sv) 2004-01-07
AU4086500A (en) 2000-12-21
NO20002941L (no) 2000-12-18
CA2312206C (fr) 2004-07-06
FR2795072A1 (fr) 2000-12-22
CN1277198A (zh) 2000-12-20
HUP0002277A2 (hu) 2001-05-28
SE1069132T3 (sv) 2003-12-09
JP3364472B2 (ja) 2003-01-08

Similar Documents

Publication Publication Date Title
NO950849D0 (no) Derivater av valproin og 2-valproensyreamider og anvendelse som antikonvulsanter
EP1103552A4 (de) Benzothiepin-derivate, verfahren zu ihrer herstellung und ihre verwendungen
MXPA05007496A (es) Tienopirimidindionas y su uso en la modulacion de enfermedades autoinmunes.
EA200600487A1 (ru) Соединения инданилпиперазина, способ их получения и содержащие их фармацевтические композиции
EA200000792A3 (ru) Новые пиридиновые соединения, способ их получения и содержащие их фармацевтические композиции
HUP0102599A2 (hu) Artemizinin-származékok, eljárás a vegyületek előállítására, és a vegyületeket tartalmazó gyógyszerészeti készítmények
DK1233953T3 (da) Nye benzoethiadiazinderivater, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende samme
MXPA03000547A (es) Uso de derivados de amidas de acido valproico y de acido 2-valproenico, para el tratamiento de manias en trastornos bipolares.
DE60005609D1 (de) Bizyklische Amino-Pyrazinon-Derivate, verfahren zu deren Herstellung und pharmazeutische Zusammensetzungen die diese enthalten
EA200100969A1 (ru) Новые соединения циклобутендиона, способ их получения и содержащие их фармацевтические композиции
ATE166345T1 (de) Benzospiroalken-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen
EA200100597A2 (ru) Новые 1,1- и 1,2-дизамещенные циклопропановые соединения, способ их получения и содержащие их фармацевтические композиции
ATE244221T1 (de) Pyrrolderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen
CO5550441A2 (es) Nuevos derivados de ziprasidona, procedimientos para prepararlos y composiciones que los contienen
EA200101204A1 (ru) Новые бициклические соединения аминопиразинона, способ их получения и содержащие их фармацевтические композиции
DE69106323T2 (de) Imidazol-Derivate, Verfahren zu deren Herstellung und diese enthaltende Zusammenstellungen.
HUP0103077A2 (hu) Új benzotiadiazinvegyületek, eljárás ezek előállítására, és ezeket tartalmazó gyógyászati készítmények
ATE34739T1 (de) Neue 2-pyridin-thiol-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate.
EA200300029A1 (ru) Новые соединения карбамат и тиокарбамат подофиллотоксина, способ их получения и содержащие их фармацевтические композиции
EA200000598A1 (ru) Новые ингибиторы металлопротеазы, способ их получения и содержащие их фармацевтические композиции
ATE23150T1 (de) Aminoethoxybenzylalkohol-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
NO20022891L (no) Nye cykliske <alfa>-amino-<gamma>-hydroksyamidforbindelser, fremgangsmåte ved deres fremstilling og farmasöytiske sammensetningerinneholdende dem
TH37483A (th) อนุพันธ์ 5-เมโรอิลแนพธาลีน
TH31600A (th) เกลือของกรดแคลวูแลนิค

Legal Events

Date Code Title Description
8364 No opposition during term of opposition